PATENT CLAIM ANALYSIS

Application Number: 15953523
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
Disclosed are heteroarylcarboxamides of formula (I), and pharmaceutically acceptable salts thereof, wherein A, T, R 1 , R 2  and R 3  are as defined herein. Also disclosed are methods of using these compounds for the treatment of diseases which can be influenced by inhibition of plasma kallikrein.

Claim (Index 5):
The compound according to  claim 1 , wherein\n R 1  is selected from the group R 1 -G3 consisting of CH 3 , or a salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.30233
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15770763', '15770762', '14365497', '15764071', '15327706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.811828375623332
- 35 USC 102 Novelty (BERT): 0.5240809280403111
- Combined Prediction Score: 0.78305363086503
- Mean Citation Score: 278.67441
- Max Citation Score: 335.30173
- Similarity Product: 235.48560672654327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test